KUALA LUMPUR: Alpha IVF Group Bhd has received approval from Bursa Malaysia Securities Bhd to list on the ACE Market of Bursa Malaysia.
Alpha IVF is a fertility care specialist currently operating in Malaysia and Singapore, providing assisted reproductive services (ARS) with a primary focus on in-vitro fertilisation (IVF). It currently operates two specialist centres in Malaysia and one specialist centre in Singapore.
Alpha IVF group managing director Datuk Dr Colin Lee Soon Soo said the approval to list on the ACE Market not only marks a significant step in its next growth stage but also reinforces its dedication to making the dreams of parenthood a reality.
“Over the years, Alpha IVF has become a trusted name in the region in helping couples on their journey to parenthood. We have consistently delivered high success rates in the field of ARS, demonstrated by our strong track record and clinical experiences.
“The growing need for ARS poses an opportune moment for our expansion, enabling us to strategically capitalize on emerging opportunities, and extending to benefit even more patients with our high pregnancy rates. The floatation exercise and Bursa Securities’ approval bring us closer to achieving our mission of becoming a leading fertility care specialist in the region,” he said in a statement.
Alpha IVF targets to be listed in the first quarter of 2024.
AmInvestment Bank Bhd is the principal adviser, sponsor, lead placement agent, joint placement agent, and sole underwriter for the group’s initial public offering exercise.
